What is AZN stock price today?

Visit our real-time dashboard for the current AZN stock price and live market data.

Is AZN stock going up or down today?

AZN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AZN stock now?

The decision to buy AZN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AZN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AZN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AZN stock overvalued or undervalued?

AZN currently trades at a P/E ratio of 28.00, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if AZN is fairly priced.

What is AZN's P/E ratio?

AZN has a price-to-earnings (P/E) ratio of 28.00, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is AZN's market cap?

AZN (AstraZeneca PLC) has a market capitalization of $288.38 billion, making it a large-cap stock.

What is AZN's price to book ratio?

Price-to-book ratio for AZN is available on our dashboard along with other valuation metrics.

Does AZN pay dividends?

Yes, AZN pays dividends with a current yield of 1.76%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is AZN's dividend yield?

AZN's dividend yield is 1.76%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is AZN stock a good long-term investment?

AZN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AZN's revenue growth rate?

Revenue growth data for AZN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for AZN are available on our dashboard with complete income statement analysis.

What are the risks of investing in AZN?

Key risks for AZN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AZN compare to its competitors?

Compare AZN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AZN's performance and positioning.

What is AZN's stock price target for 2026?

Visit our prediction page for AI-powered price targets for AZN with bull, base, and bear case scenarios.

What do analysts say about AZN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AZN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AZN's next earnings report?

AZN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AZN - AstraZeneca PLC

NYSE * Healthcare * Drug Manufacturers - General

$0.00

+$0.00 (+0.00%)

About AstraZeneca PLC

AstraZeneca PLC (AZN) common stock

Price Chart

Loading chart...

AZN Key Statistics

Market Cap

$288.38B

P/E Ratio

28.00

Dividend Yield

1.76%

How AZN Compares to Peers

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
AZN(This stock)	$288.38B	28.0	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 22, 2026 at 5:28 AM EDT

Ready to invest in AZN?

Commission-free trading available. Affiliate links.

Upcoming Events for AZN

Dashboard

Enter a ticker to analyze